The number I remember is the AGM in Sydney in 2017 when Axel gave Imugene a valuation if it was listed in the States, $500m from memory(he didn’t state currency so I’d assume $US as it’s where works and lives)...it was blurred out in the video. His extremely conservative bias was bought to account no doubt.
We have global scientific heads attaching their names to the company, clinical results excelling, MD and Chair seriously loading up on options, serious platform expansion and fully funded out to 2022.
Sit back and relax...let bj, jatter and the traders allow you to accumulate. It’s what I’m doing.
Another $8 Billion Pharma/Oncology deal!, page-22
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
